Hong Kong Clears Europharm Products Of Fungus, Plant Still Shut
This article was originally published in PharmAsia News
Executive Summary
Hong Kong health authorities have now cleared all 359 of Europharm's drug products of containing a fungal growth found in gout products. Although the Hong Kong Department of Health said it plans to continue testing, it said examinations of 39 raw material samples from the drug maker uncovered none of the Rhizopus microsporus fungus implicated in at least six Hong Kong fatalities. But the department also said Europharm could not resume manufacturing operations until it has improved its production lines to the satisfaction of authorities. (Click here for more
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.